Coordination
Advisory Board
Partners

Coordination Committee

The role of the Committee

The Coordination Committee is the central body that oversees, implements the programme, and coordinates tightly with the centres’ Directorates and PhD programmes. The Committee is composed of a representative from each Hiring Research Centre. The representatives cover a wide range of expertise from academic affairs, researcher training, research strategy and management, and excellent basic and translational research. The Coordination Committee is supported by the Programme Manager.

Jorge Ferrer, MD PhD
Chair of Coordination Committee and Project Coordinator

Senior Group Leader of the Regulatory Genomics and Diabetes lab at Centre of Genomic Regulation (CRG), Barcelona, Spain

Jorge Ferrer, is the senior group leader of Regulatory Genomics and Diabetes lab (CRG), Coordinator of the Medical Genomics Research Programme (CRG), and Professor and Section Head at the Imperial College London.

Michela Bertero, PhD
Coordination Committee member

Head of International and Scientific Affairs at the Centre of Genomic Regulation (CRG), Barcelona, Spain

Michela Bertero is the Strategy Director of IDIBAPS. She has been instrumental in the creation of EU-LIFE, as well as the launch of the joint Catalan MD-PhD programme PhD4MD (https://phd4md.crg.eu), which set the basis of the EMERALD Programme, for which she was a key driver and former Coordinator. Michela is passionate about Open Science, the gender dimension in research, and the MD-PhD career track.

Henri van Luenen, PhD
Coordination Committee member

Director of Operations at the Netherlands Cancer Institute (NKI), The Netherlands

Henri van Luenen studied biology at the Free University in Amsterdam. In 1987 he joined the Netherlands Cancer Institute (NKI) in Amsterdam and a year later started his PhD project (molecular analysis of DNA transposition in C. elegans) under the supervision of Prof. Ronald Plasterk. In 1995 he obtained his PhD degree and continued as a postdoctoral fellow; first in the research group of Prof. Plasterk and later in the group of Prof. Piet Borst working on the molecular biology of L. tarantolae and T. brucei (function and biosynthesis if DNA base J). Next to his scientific work, he started in 1997 as Director of Operations at the NKI. As Director of operations, in close collaboration with the Director of Research, he is responsible for creating and maintaining a state-of-the-art research institute.

François Doz, MD
Coordination Committee member

Director of advanced training of the IC Hospital Group, Institut Curie, France

François Doz MD is a paediatrician oncologist, professor of paediatrics at Paris University, deputy director of clinical research, innovation and teaching in the SIREDO Oncology centre of IC (Care, Innovation and research in Cancer of the child, adolescent and young adult) and director of advanced training of the IC Hospital Group; he is the coordinator of Institut Curie PhD programme for MDs and Pharmacists.

Katrine Sonne-Hansen, PhD
Coordination Committee member

Head of Strategic Research Support at BRIC, Denmark

Katrine Sonne-Hansen has wide experience with researcher training under the MSCA programme. She currently sit in the programme committee for the PhD-programme iMED (www.imed.ku.dk) and coordinates the LEAD postdoc-programme (www.lead.ku.dk) and the DISCOVER PhD-programme (www.discover.ku.dk). She has a background in cancer research and has for the last 10 years worked with research strategy, research communication and researcher training. She heads BRIC’s Strategic Research Support Office and is part of BRIC’s management team.

Michaela Herzig, PhD
Coordination Committee member

Head of Graduate School and Academic Training at Max Delbrück Center for Molecular Medicine (MDC), Germany

Michaela Herzig is coordinating the Graduate School and Academic Training Program of the Max-Delbrück Center for Molecular Medicine (MDC) Berlin. Michaela studied Chemistry at the Universität Wien and completed her PhD in molecular oncology before moving on to work at the interface of research and project management. Currently, she is responsible for the management of the MDC Graduate School, an umbrella structure of various graduate and international exchange programs, coordination of academic cooperations and the Career Center at MDC.

Luís Ferreira Moita, MD PhD
Coordination Committee member

Senior Group Leader of Innate Immunity and Inflammation lab at Instituto Gulbenkian de Ciência (IGC), Portugal

Luís Ferreira Moita is the head of the Innate Immunity and Inflammation Laboratory at the Instituto Gulbenkian de Ciência (Oeiras, Portugal). He did post-doctoral work with Nir Hacohen at the Whitehead Institute and Mass. General Hospital (Boston, USA) after completing his PhD at the European Molecular Biology Laboratory (Heidelberg, Germany) under the supervision of Fotis Kafatos and graduating from medical school at the University of Lisbon. The central goals of his laboratory are to understand how stress responses modulate organismal homeostasis and how that knowledge can be harnessed for therapeutic applications. Luís, an MD PhD himself, has been closely involved in the development of the MD-PhD career track.

Lieve Ongena, PhD
Coordination Committee member

Sr Science Policy Manager & Head of International Grants office at VIB, Belgium

Lieve Ongena has been involved in EU science policy for more than 20 years. She is heading the International Grants Office with a focus on ERC and individual MSCA applications and coordinated the Omics@VIB postdoctoral MSCA-COFUND program. Lieve is very much involved in Open Science and the gender dimension in research. She is a member of VIB’s management team.

David Brena, PhD
Programme Manager

Scientific Project Manager at International and Scientific Affairs Centre of Genomic Regulation (CRG), Barcelona, Spain

David Brena is a Scientific Project Manager in the International & Scientific Affairs Office at CRG, focused on the creation and management of international collaborative EC-funded projects. He has a PhD in biomedicine and has worked a great part of his career in hospitals in Mexico and Spain, providing him with a big picture of the needs of the basic researcher and medical community.

Advisory Board

The role of the Advisory Board

Raquel Yotti Álvarez, MD
Advisory Board member

Secretary General for Research in Spain

Raquel Yotti Álvarez is a clinical researcher for the National Health System, a Doctor of Medicine and Surgery from the Complutense University of Madrid and a specialist in cardiology.

Anthony Man, PhD
Advisory Board member

Therapeutic Area Head, Communicable Diseases Global Health Development Unit at Novartis Pharma in Switzerland

Anthony Man is the Global Clinical Development Head for Communicable Diseases at Novartis Pharma in Basel, Switzerland. He is a medically qualified professional with over 30 years of international drug development experience in the pharmaceutical and biotechnology industry.

Adriano Aguzzi, MD PhD
Advisory Board member

Director Institute of Neuropathology at University of Zurich

Adriano Aguzzi is professor and director of the Institute of Neuropathology at the University of Zurich. He has devoted the past 25 years to studying the immunological and molecular basis of prion pathogenesis. He is directing the MDPhD Programme at the University of Zurich.

Christina Sylvester-Hvid, PhD
Advisory Board member

Business Development Liaison Nordics, Medical Immuno Oncology Bristol-Myers Squibb

Christina Sylvester-Hvid is Immuno-oncology expert and respnsible for Nordics business development at Bristol-Myers Squibb. Additionally she is associate Professor at University of Copenhagen, Faculty of Health and Medical Sciences.

Partner Organisations

We rely on 37 Partner Organisations from 10 European countries that will offer internships to research fellows and support our innovative training plan.

MEET THE PARTNERS